Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Melanie Börries"'
Autor:
Julia C. Kuehn, Patrick Metzger, Nicolas Neidert, Uta Matysiak, Linda Gräßel, Ulrike Philipp, Sabine Bleul, Thomas Pauli, Julia Falkenstein, Henriette Bertemes, Stepan Cysar, Maria Elena Hess, Anna Verena Frey, Jesús Duque-Afonso, Elisabeth Schorb, Marcia Machein, Jürgen Beck, Oliver Schnell, Nikolas von Bubnoff, Anna L. Illert, Christoph Peters, Tilman Brummer, Marco Prinz, Cornelius Miething, Heiko Becker, Silke Lassmann, Martin Werner, Melanie Börries, Justus Duyster, Dieter H. Heiland, Roman Sankowski, Florian Scherer
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Despite major advances in molecular profiling and classification of primary brain tumors, personalized treatment remains limited for most patients. Here, we explored the feasibility of individual molecular profiling and the efficacy of bioma
Externí odkaz:
https://doaj.org/article/1dc07143d8964d58a48d87e8eab4e848
Autor:
Christian Molnar, Sheila Bohler, Jovana Rajak, Julia Miriam Weiss, Irene Gonzalez-Mendez, Geoffroy Andrieux, Eva-Maria Demmerath, Madeleine Wahl, Lena Wendeburg, Gudrun Göhring, Brigitte Strahm, Doris Steinemann, Martina Rudelius, Melanie Börries, Leticia Quintanilla-Martinez, Charlotte M. Niemeyer, Verena Labi, Miriam Erlacher
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100069- (2023)
Externí odkaz:
https://doaj.org/article/eb53d0919a71441d88fd83a5986a697d
Autor:
Silvia Waldeck, Jan Mitschke, Sebastian Wiesemann, Michael Rassner, Geoffroy Andrieux, Max Deuter, Jurik Mutter, Anne‐Marie Lüchtenborg, Daniel Kottmann, Laurin Titze, Christoph Zeisel, Martina Jolic, Ulrike Philipp, Silke Lassmann, Peter Bronsert, Christine Greil, Justyna Rawluk, Heiko Becker, Lisa Isbell, Alexandra Müller, Soroush Doostkam, Bernward Passlick, Melanie Börries, Justus Duyster, Julius Wehrle, Florian Scherer, Nikolas von Bubnoff
Publikováno v:
Molecular Oncology, Vol 16, Iss 2, Pp 527-537 (2022)
Circulating tumor DNA (ctDNA) has demonstrated great potential as a noninvasive biomarker to assess minimal residual disease (MRD) and profile tumor genotypes in patients with non‐small‐cell lung cancer (NSCLC). However, little is known about its
Externí odkaz:
https://doaj.org/article/4399d10b1bd049f3a353a6cfadf469f6
Autor:
Anie P. Masilamani, Rana Schulzki, Shuai Yuan, Ira V. Haase, Eva Kling, Franziska Dewes, Geoffroy Andrieux, Melanie Börries, Oliver Schnell, Dieter H. Heiland, Oliver Schilling, Roberto Ferrarese, Maria S. Carro
Publikováno v:
iScience, Vol 25, Iss 7, Pp 104625- (2022)
Summary: Proteolytic cleavage is an important post-translational mechanism to increase protein variability and functionality. In cancer, this process can be deregulated to shut off tumor-suppressive functions. Here, we report that in glioblastoma (GB
Externí odkaz:
https://doaj.org/article/010c74390fea42cf89273a755f0a99a0
Autor:
Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld, Sara Costa-Pereira, Lukas Rindlisbacher, Tobias Wertheimer, Lukas M. Braun, Geoffroy Andrieux, Sandra Duquesne, Dietmar Pfeifer, Nadine M. Woessner, Hans D. Menssen, Sanaz Taromi, Justus Duyster, Melanie Börries, Tilman Brummer, Bruce R. Blazar, Susana Minguet, Patrick Turko, Mitchell P. Levesque, Burkhard Becher, Robert Zeiser
Publikováno v:
Molecular Cancer Research. :OF1-OF16
The treatment of patients with metastatic melanoma with immune checkpoint inhibitors (ICI) leads to impressive response rates but primary and secondary resistance to ICI reduces progression-free survival. Novel strategies that interfere with resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::732a48fefa5f89cc03d8544d6bfa296a
https://doi.org/10.1158/1541-7786.mcr-22-0898
https://doi.org/10.1158/1541-7786.mcr-22-0898
Autor:
Robert Zeiser, Burkhard Becher, Mitchell P. Levesque, Patrick Turko, Susana Minguet, Bruce R. Blazar, Tilman Brummer, Melanie Börries, Justus Duyster, Sanaz Taromi, Hans D. Menssen, Nadine M. Woessner, Dietmar Pfeifer, Sandra Duquesne, Geoffroy Andrieux, Lukas M. Braun, Tobias Wertheimer, Lukas Rindlisbacher, Sara Costa-Pereira, Stefan Richtsfeld, Sophie Giesler, Marlene Langenbach
The treatment of patients with metastatic melanoma with immune checkpoint inhibitors (ICI) leads to impressive response rates but primary and secondary resistance to ICI reduces progression-free survival. Novel strategies that interfere with resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f227deb934c8c58d49727aa6c44e18
https://doi.org/10.1158/1541-7786.c.6628382.v1
https://doi.org/10.1158/1541-7786.c.6628382.v1
Autor:
Robert Zeiser, Burkhard Becher, Mitchell P. Levesque, Patrick Turko, Susana Minguet, Bruce R. Blazar, Tilman Brummer, Melanie Börries, Justus Duyster, Sanaz Taromi, Hans D. Menssen, Nadine M. Woessner, Dietmar Pfeifer, Sandra Duquesne, Geoffroy Andrieux, Lukas M. Braun, Tobias Wertheimer, Lukas Rindlisbacher, Sara Costa-Pereira, Stefan Richtsfeld, Sophie Giesler, Marlene Langenbach
Supplementary Figures Legends and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c16a74ced8b40eb135e57100a09850
https://doi.org/10.1158/1541-7786.22743773
https://doi.org/10.1158/1541-7786.22743773
Autor:
Oliver Schnell, Daniel Delev, Irina Mader, Stefan Weber, Marco Prinz, Maria Stella Carro, Darren Ó. hAilín, Mark Bartholomae, Sabrina Heynckes, Pamela Franco, Nils Pompe, Jakob Wörner, Melanie Börries, Annette Gaebelein, Dieter Henrik Heiland
The supplementary data contains a table of used chemicals and reagents, additional experimental procedures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665e4c988995dba7caa7717cfe1dd328
https://doi.org/10.1158/1541-7786.22515369.v1
https://doi.org/10.1158/1541-7786.22515369.v1
Autor:
Oliver Schnell, Daniel Delev, Irina Mader, Stefan Weber, Marco Prinz, Maria Stella Carro, Darren Ó. hAilín, Mark Bartholomae, Sabrina Heynckes, Pamela Franco, Nils Pompe, Jakob Wörner, Melanie Börries, Annette Gaebelein, Dieter Henrik Heiland
The evolving and highly heterogeneous nature of malignant brain tumors underlies their limited response to therapy and poor prognosis. In addition to genetic alterations, highly dynamic processes, such as transcriptional and metabolic reprogramming,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d23267b63005938ac5c9eb7def7b75
https://doi.org/10.1158/1541-7786.c.6541062.v1
https://doi.org/10.1158/1541-7786.c.6541062.v1
Autor:
Justyna Rawluk, Anne-Marie Lüchtenborg, Peter Bronsert, Julius Wehrle, Nikolas von Bubnoff, Martina Jolic, Alexandra Müller, Jan Mitschke, Silvia Waldeck, Melanie Börries, Justus Duyster, Soroush Doostkam, Laurin Titze, Heiko Becker, Christoph Zeisel, Sebastian Wiesemann, Silke Lassmann, Max Deuter, Daniel Kottmann, Florian Scherer, Jurik Mutter, Ulrike Philipp, Bernward Passlick, Lisa K. Isbell, Geoffroy Andrieux, Michael Rassner, Christine Greil
Publikováno v:
Molecular Oncology, Vol 16, Iss 2, Pp 527-537 (2022)
Molecular Oncology
Molecular Oncology
Circulating tumor DNA (ctDNA) has demonstrated great potential as a noninvasive biomarker to assess minimal residual disease (MRD) and profile tumor genotypes in patients with non‐small‐cell lung cancer (NSCLC). However, little is known about its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c8651987bd2205a3913f99851c2d001
https://doaj.org/article/4399d10b1bd049f3a353a6cfadf469f6
https://doaj.org/article/4399d10b1bd049f3a353a6cfadf469f6